Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
88.27 EUR | +0.64% | -2.10% | -1.66% |
03:51pm | Sanofi: acquisition of Inhibrx finalized | CF |
05-28 | EU okays $1.5 bln state funded joint hydrogen project, $1.1 bln joint healthcare project | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.66% | 119B | |
+39.31% | 731B | |
+31.99% | 586B | |
-7.98% | 348B | |
+15.69% | 319B | |
-0.39% | 273B | |
+13.64% | 235B | |
-6.67% | 203B | |
+7.47% | 202B | |
+2.89% | 159B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi : Aubagio Drug Gets European Approval as Oral Multiple Sclerosis Therapy for Children, Adolescents